Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage
- 14 December 2004
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 385 (1) , 279-287
- https://doi.org/10.1042/bj20040959
Abstract
Quinone reductase (QR) is a phase II detoxification enzyme that plays an important role in detoxifying quinones and may help maintain the antioxidant function of the cell. We have previously observed that QR is up-regulated by anti-oestrogens, but not oestrogen, in breast cancer cells via ERbeta (oestrogen receptor beta) transactivation. Such QR induction appears to protect breast cells against oestrogen-induced oxidative DNA damage, most likely by reducing reactive oestrogen metabolites termed catecholestrogen-quinones back to the hydroxy-catecholestrogens which may be conjugated. We now report that the phytoestrogens biochanin A, genistein and resveratrol also up-regulate QR expression in breast cancer cells. We observe that regulation can occur at the transcriptional level, preferentially through ERbeta transactivation at the electrophile response element of the QR gene promoter. By chromatin immunoprecipitation analysis, we show binding of ERalpha and ERbeta to the QR promoter, with increased ERbeta binding in the presence of resveratrol. Functional studies show that biochanin A and resveratrol, but not genistein, can significantly protect against oestrogen-induced oxidative DNA damage in breast cancer cells. Antisense technology was used to determine whether such protection was dependent on ERbeta or QR. Our results with resveratrol are consistent with our hypothesis that the protective ability of resveratrol is partially dependent on the presence of ERbeta and QR. In conclusion, we postulate that phytoestrogen-mediated induction of QR may represent an additional mechanism for breast cancer protection, although the effects may be specific for a given phytoestrogen.Keywords
This publication has 51 references indexed in Scilit:
- Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancerBritish Journal of Nutrition, 2004
- Genistein and Daidzein Induce Cell Proliferation and Their Metabolites Cause Oxidative DNA Damage in Relation to Isoflavone-Induced Cancer of Estrogen-Sensitive OrgansBiochemistry, 2004
- Italian Randomized Trial Among Women With Hysterectomy: Tamoxifen and Hormone-Dependent Breast Cancer in High-Risk WomenJNCI Journal of the National Cancer Institute, 2003
- Interaction of Phytoestrogens with Estrogen Receptors .ALPHA. and .BETA.(II).Biological & Pharmaceutical Bulletin, 2002
- Phytoestrogens after breast cancer.Endocrine-Related Cancer, 2001
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000
- Identification and Characterization of a Novel Factor That Regulates Quinone Reductase Gene Transcriptional ActivityJournal of Biological Chemistry, 2000
- Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonistThe EMBO Journal, 1999
- Transcriptional Regulation of the Human Quinone Reductase Gene by Antiestrogen-liganded Estrogen Receptor-α and Estrogen Receptor-βJournal of Biological Chemistry, 1998
- Inhibition of UV light- and Fenton Reaction-induced oxidative DNA damage by the soybcan isoflavone genisteinCarcinogenesis: Integrative Cancer Research, 1996